Viewing StudyNCT02763566



Ignite Creation Date: 2024-05-06 @ 8:34 AM
Last Modification Date: 2024-10-26 @ 12:01 PM
Study NCT ID: NCT02763566
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-16
First Post: 2016-05-04

Brief Title: A Study of Abemaciclib LY2835219 in Participants With Breast Cancer
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
CDK6 View
Hormone Receptor-Positive View
HER2-Negative View
CDK4 View